A prostate cancer survivor who lost all three of his brothers to the disease has urged black men with a family history to get ...
The trial involves a PSMA-directed T cell engager using Janux’s tumour-activated platform to activate T cells.
A 64-year-old with advanced prostate cancer underwent robotic surgery after hormonal therapy, achieving successful tumour ...
Lubbock local Gene Turnipseed has lived in Lubbock since 1975, and while the city has certainly changed over the years, his ...
Today, the American Urological Association (AUA), in partnership with the American Society for Radiation Oncology (ASTRO), ...
A Hawke’s Bay man has become the first patient in the region to receive low-dose-rate (LDR) brachytherapy, a “minimally ...
Belgium's challenge reflects a broader EU dilemma on how to translate next-generation cancer innovation into real-world ...
Dr. Sandy Srinivas explains how age, comorbidities and medications influence personalized prostate cancer treatment decisions ...
From his perspective, one of the most persistent misconceptions in prostate cancer care relates to how patients interpret ...
While Lucas was widely known for his extraordinary car collection and exacting standards, his philanthropy was intentionally quiet. His giving to Saint John’s was deeply personal - rooted in the close ...
A former Leicester doctor has been accused of charging thousands of pounds for fake medical treatments to a patient with ...
PRO-XTEN dual masking aims to keep the engager inactive in circulation, activate within tumor protease-rich microenvironments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results